Back

Effects of colchicine on platelet reactivity among stable post-myocardial infarction patients: a double-blind randomized controlled trial.

29 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Novel aspects of the revascularisation of patients with chronic and acute coronary syndromes Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Maria Carolina Diez Andrade

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)

5 More presentations in this session

Presentation thumbnail
Plaque inflammation and noncalcified burden predict adverse events after percutaneous coronary intervention
Doctor Z. Lu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Left anterior descending artery lesions retain excess risk despite coronary angiography derived-fractional flow reserve concordant revascularisation
Miss H. Sze (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of drug-coated balloon angioplasty in patients with acute coronary syndromes: insights from the REC-CAGEFREE I trial
Professor C. Gao (Hefei, CN)
Presentation thumbnail
Comparing the impact of intravascular imaging, fractional flow reserve, and angiographic guidance on one-year outcomes of PCI in patients with chronic coronary syndromes: an emulated trial
Mr B. Ratanasumawong (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Can lipoprotein(a) predict the need for coronary artery revascularization in a chronic setting?
Doctor D. Besic (Zagreb, HR)
Abstract Slides Video

Access the full session

Session thumbnail
Novel aspects of the revascularisation of patients with chronic and acute coronary syndromes

The Event

Event poster

ESC Congress 2026

29 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Colchicine in patients with acute myocardial infarction: an updated meta-analysis of randomized controlled trials
27 August 2021
thumbnail
Congress Presentation
Thrombin generation and platelet function in patients on RAAS inhibitors
2 September 2019
thumbnail
Congress Presentation
Influence of therapy in patients with CAD and type 2 diabetes on inflamation biomarkers P-selectin and Galectin-3 changes
20 May 2023
thumbnail
Congress Presentation
Optimizing post-PCI therapy: ticagrelor, prasugrel, clopidogrel, and cilostazol reduce early MACE
21 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources